ID   MTMRE_HUMAN             Reviewed;         650 AA.
AC   Q8NCE2; Q0JTH5; Q0JU83; Q6PIZ4; Q6QE21; Q86VK9; Q8IYK1; Q8TCM7; Q9H6C0;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   27-MAR-2024, entry version 158.
DE   RecName: Full=Myotubularin-related protein 14;
DE            EC=3.1.3.-;
DE   AltName: Full=HCV NS5A-transactivated protein 4 splice variant A-binding protein 1;
DE            Short=NS5ATP4ABP1;
DE   AltName: Full=hJumpy;
GN   Name=MTMR14; Synonyms=C3orf29;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Chen L.D., Cheng J., Wang Q., Hong Y., Zhang L.F., Han L., Yuan J.;
RT   "Screening and cloning of interaction protein 1 of HCV NS5A-transactivated
RT   protein 4 splice variant A.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Kidney epithelium, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Duodenal adenocarcinoma, Leukocyte, Retinal pigment epithelium,
RC   and Rhabdomyosarcoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 403-557 (ISOFORM 1).
RC   TISSUE=Melanoma;
RA   Sales M.M., Ferrasi A.C., Pereira A.A., Pardini M.I.M.C., Sogayar M.C.,
RA   Camargo A.A.;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION, INVOLVEMENT IN CNM1 AS MODIFIER OF PHENOTYPE, VARIANTS CNM1
RP   GLN-336 AND CYS-462, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF CYS-330.
RX   PubMed=17008356; DOI=10.1093/hmg/ddl250;
RA   Tosch V., Rohde H.M., Tronchere H., Zanoteli E., Monroy N., Kretz C.,
RA   Dondaine N., Payrastre B., Mandel J.-L., Laporte J.;
RT   "A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating
RT   variant in centronuclear myopathy.";
RL   Hum. Mol. Genet. 15:3098-3106(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-580, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518; SER-530 AND SER-624, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-638, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Lipid phosphatase which efficiently dephosphorylates
CC       phosphatidylinositol 3-phosphate (PtdIns3P) and PtdIns(3,5)P2; inactive
CC       toward PtdIns4P, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3.
CC       {ECO:0000269|PubMed:17008356}.
CC   -!- INTERACTION:
CC       Q8NCE2; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-5658424, EBI-11952721;
CC       Q8NCE2; Q13625-3: TP53BP2; NbExp=3; IntAct=EBI-5658424, EBI-10175039;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17008356}.
CC       Note=Found in reticular structures and plasma membrane ruffles.
CC       Concentrated near the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NCE2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NCE2-2; Sequence=VSP_021586;
CC       Name=3;
CC         IsoId=Q8NCE2-3; Sequence=VSP_021585, VSP_021586;
CC   -!- TISSUE SPECIFICITY: Expressed in various tissues, including heart,
CC       skeletal muscle, placenta, liver, lung, kidney and pancreas.
CC       {ECO:0000269|PubMed:17008356}.
CC   -!- DISEASE: Myopathy, centronuclear, 1 (CNM1) [MIM:160150]: A congenital
CC       muscle disorder characterized by progressive muscular weakness and
CC       wasting involving mainly limb girdle, trunk, and neck muscles. It may
CC       also affect distal muscles. Weakness may be present during childhood or
CC       adolescence or may not become evident until the third decade of life.
CC       Ptosis is a frequent clinical feature. The most prominent
CC       histopathologic features include high frequency of centrally located
CC       nuclei in muscle fibers not secondary to regeneration, radial
CC       arrangement of sarcoplasmic strands around the central nuclei, and
CC       predominance and hypotrophy of type 1 fibers.
CC       {ECO:0000269|PubMed:17008356}. Note=The gene represented in this entry
CC       may act as a disease modifier. MTMR14 mutations affecting enzymatic
CC       function have been found in sporadic cases of centronuclear myopathy,
CC       one of them carrying a disease-associated mutation in DNM2
CC       (PubMed:17008356). This raises the possibility of MTMR14 being a
CC       modifier of the phenotype in some cases of centronuclear myopathy
CC       (PubMed:17008356). {ECO:0000269|PubMed:17008356}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class myotubularin subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15340.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ630520; ABG02221.1; -; mRNA.
DR   EMBL; AK026058; BAB15340.1; ALT_INIT; mRNA.
DR   EMBL; AK074792; BAC11211.1; -; mRNA.
DR   EMBL; AL713695; CAD28494.1; -; mRNA.
DR   EMBL; AM393309; CAL38187.1; -; mRNA.
DR   EMBL; AM393050; CAL37928.1; -; mRNA.
DR   EMBL; BC001674; AAH01674.2; -; mRNA.
DR   EMBL; BC025952; AAH25952.2; -; mRNA.
DR   EMBL; BC035690; AAH35690.1; -; mRNA.
DR   EMBL; BC050626; AAH50626.1; -; mRNA.
DR   EMBL; AY545552; AAS50151.1; -; mRNA.
DR   CCDS; CCDS43043.1; -. [Q8NCE2-1]
DR   CCDS; CCDS43044.1; -. [Q8NCE2-2]
DR   CCDS; CCDS43045.1; -. [Q8NCE2-3]
DR   RefSeq; NP_001070993.1; NM_001077525.2. [Q8NCE2-1]
DR   RefSeq; NP_001070994.1; NM_001077526.2. [Q8NCE2-2]
DR   RefSeq; NP_071930.2; NM_022485.4. [Q8NCE2-3]
DR   AlphaFoldDB; Q8NCE2; -.
DR   BioGRID; 122168; 119.
DR   IntAct; Q8NCE2; 44.
DR   MINT; Q8NCE2; -.
DR   STRING; 9606.ENSP00000296003; -.
DR   DEPOD; MTMR14; -.
DR   GlyCosmos; Q8NCE2; 2 sites, No reported glycans.
DR   GlyGen; Q8NCE2; 2 sites.
DR   iPTMnet; Q8NCE2; -.
DR   PhosphoSitePlus; Q8NCE2; -.
DR   BioMuta; MTMR14; -.
DR   DMDM; 118568016; -.
DR   EPD; Q8NCE2; -.
DR   jPOST; Q8NCE2; -.
DR   MassIVE; Q8NCE2; -.
DR   MaxQB; Q8NCE2; -.
DR   PaxDb; 9606-ENSP00000296003; -.
DR   PeptideAtlas; Q8NCE2; -.
DR   ProteomicsDB; 72881; -. [Q8NCE2-1]
DR   ProteomicsDB; 72882; -. [Q8NCE2-2]
DR   ProteomicsDB; 72883; -. [Q8NCE2-3]
DR   Pumba; Q8NCE2; -.
DR   Antibodypedia; 25426; 304 antibodies from 26 providers.
DR   DNASU; 64419; -.
DR   Ensembl; ENST00000296003.9; ENSP00000296003.5; ENSG00000163719.20. [Q8NCE2-1]
DR   Ensembl; ENST00000351233.9; ENSP00000334070.7; ENSG00000163719.20. [Q8NCE2-3]
DR   Ensembl; ENST00000353332.9; ENSP00000323462.8; ENSG00000163719.20. [Q8NCE2-2]
DR   GeneID; 64419; -.
DR   KEGG; hsa:64419; -.
DR   MANE-Select; ENST00000296003.9; ENSP00000296003.5; NM_001077525.3; NP_001070993.1.
DR   UCSC; uc003brz.4; human. [Q8NCE2-1]
DR   AGR; HGNC:26190; -.
DR   CTD; 64419; -.
DR   DisGeNET; 64419; -.
DR   GeneCards; MTMR14; -.
DR   HGNC; HGNC:26190; MTMR14.
DR   HPA; ENSG00000163719; Low tissue specificity.
DR   MalaCards; MTMR14; -.
DR   MIM; 160150; phenotype.
DR   MIM; 611089; gene.
DR   neXtProt; NX_Q8NCE2; -.
DR   OpenTargets; ENSG00000163719; -.
DR   Orphanet; 169189; Autosomal dominant centronuclear myopathy.
DR   PharmGKB; PA162396265; -.
DR   VEuPathDB; HostDB:ENSG00000163719; -.
DR   eggNOG; ENOG502QQ9R; Eukaryota.
DR   GeneTree; ENSGT00390000018852; -.
DR   HOGENOM; CLU_016325_2_0_1; -.
DR   InParanoid; Q8NCE2; -.
DR   OMA; HFSQPMA; -.
DR   OrthoDB; 1334300at2759; -.
DR   PhylomeDB; Q8NCE2; -.
DR   TreeFam; TF324044; -.
DR   BioCyc; MetaCyc:HS08920-MONOMER; -.
DR   BRENDA; 3.1.3.64; 2681.
DR   PathwayCommons; Q8NCE2; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   SignaLink; Q8NCE2; -.
DR   BioGRID-ORCS; 64419; 10 hits in 1179 CRISPR screens.
DR   ChiTaRS; MTMR14; human.
DR   GeneWiki; MTMR14; -.
DR   GenomeRNAi; 64419; -.
DR   Pharos; Q8NCE2; Tbio.
DR   PRO; PR:Q8NCE2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8NCE2; Protein.
DR   Bgee; ENSG00000163719; Expressed in monocyte and 192 other cell types or tissues.
DR   ExpressionAtlas; Q8NCE2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0052629; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; TAS:Reactome.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome.
DR   GO; GO:0016311; P:dephosphorylation; IEA:InterPro.
DR   GO; GO:0016236; P:macroautophagy; TAS:Reactome.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   CDD; cd13213; PH-GRAM_MTMR14; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR039802; MTMR14.
DR   InterPro; IPR039803; MTMR14_PH-GRAM.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   PANTHER; PTHR13524; MYOTUBULARIN-RELATED; 1.
DR   PANTHER; PTHR13524:SF2; MYOTUBULARIN-RELATED PROTEIN 14; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   Genevisible; Q8NCE2; HS.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Disease variant;
KW   Glycoprotein; Hydrolase; Methylation; Phosphoprotein; Reference proteome.
FT   CHAIN           1..650
FT                   /note="Myotubularin-related protein 14"
FT                   /id="PRO_0000260214"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          476..546
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        477..526
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        330
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         194
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         518
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         530
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336"
FT   MOD_RES         624
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         638
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   CARBOHYD        226
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        519
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         479..538
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_021585"
FT   VAR_SEQ         539..590
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|Ref.1"
FT                   /id="VSP_021586"
FT   VARIANT         336
FT                   /note="R -> Q (in CNM1; may act as a phenotype modifier;
FT                   drastically reduced enzymatic activity; dbSNP:rs121434509)"
FT                   /evidence="ECO:0000269|PubMed:17008356"
FT                   /id="VAR_033370"
FT   VARIANT         462
FT                   /note="Y -> C (in CNM1; may act as a disease modifier;
FT                   mutation found in a patient also carrying mutation Lys-368
FT                   in DNM2; reduced enzymatic activity; dbSNP:rs121434510)"
FT                   /evidence="ECO:0000269|PubMed:17008356"
FT                   /id="VAR_033371"
FT   MUTAGEN         330
FT                   /note="C->S: Drastically reduced enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:17008356"
FT   CONFLICT        28
FT                   /note="G -> R (in Ref. 3; CAL38187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        55
FT                   /note="E -> G (in Ref. 3; CAL37928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126
FT                   /note="R -> G (in Ref. 3; CAL38187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390
FT                   /note="F -> S (in Ref. 2; BAC11211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403..406
FT                   /note="EEFS -> ALFA (in Ref. 5; AAS50151)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        554..557
FT                   /note="GSWQ -> AAGM (in Ref. 5; AAS50151)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        646
FT                   /note="S -> N (in Ref. 3; CAL37928)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   650 AA;  72203 MW;  C1B70E5140EF0716 CRC64;
     MAGARAAAAA ASAGSSASSG NQPPQELGLG ELLEEFSRTQ YRAKDGSGTG GSKVERIEKR
     CLELFGRDYC FSVIPNTNGD ICGHYPRHIV FLEYESSEKE KDTFESTVQV SKLQDLIHRS
     KMARCRGRFV CPVILFKGKH ICRSATLAGW GELYGRSGYN YFFSGGADDA WADVEDVTEE
     DCALRSGDTH LFDKVRGYDI KLLRYLSVKY ICDLMVENKK VKFGMNVTSS EKVDKAQRYA
     DFTLLSIPYP GCEFFKEYKD RDYMAEGLIF NWKQDYVDAP LSIPDFLTHS LNIDWSQYQC
     WDLVQQTQNY LKLLLSLVNS DDDSGLLVHC ISGWDRTPLF ISLLRLSLWA DGLIHTSLKP
     TEILYLTVAY DWFLFGHMLV DRLSKGEEIF FFCFNFLKHI TSEEFSALKT QRRKSLPARD
     GGFTLEDICM LRRKDRGSTT SLGSDFSLVM ESSPGATGSF TYEAVELVPA GAPTQAAWRK
     SHSSSPQSVL WNRPQPSEDR LPSQQGLAEA RSSSSSSSNH SDNFFRMGSS PLEVPKPRSV
     DHPLPGSSLS TDYGSWQMVT GCGSIQERAV LHTDSSLPFS FPDELPNSCL LAALSDRETR
     LQEVRSAFLA AYSSTVGLRA VAPSPSGAIG GLLEQFARGV GLRSISSNAL
//